Insights into cytomegalovirus-associated T cell receptors in recipients following allogeneic hematopoietic stem cell transplantation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Insights into cytomegalovirus-associated T cell receptors in recipients following allogeneic hematopoietic stem cell transplantation ; volume:21 ; number:1 ; day:30 ; month:9 ; year:2024 ; pages:1-11 ; date:12.2024
Virology journal ; 21, Heft 1 (30.9.2024), 1-11, 12.2024
- Urheber
-
Xia, Jintao
Xiao, Yingjun
Gui, Genyong
Gong, Shengnan
Wang, Huiqi
Li, Xuejie
Yan, Ren
Fan, Jun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-024-02511-x
- URN
-
urn:nbn:de:101:1-2412172108002.187302788648
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xia, Jintao
- Xiao, Yingjun
- Gui, Genyong
- Gong, Shengnan
- Wang, Huiqi
- Li, Xuejie
- Yan, Ren
- Fan, Jun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients—evaluation of pre-transplant risk assessments
Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients - evaluation of pre-transplant risk assessments
Impact of graft invariant natural killer T cells on early cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients
Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients—evaluation of pre-transplant risk assessments
Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients - evaluation of pre-transplant risk assessments
Impact of graft invariant natural killer T cells on early cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients
Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States
Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients—evaluation of pre-transplant risk assessments
Ageing-resembling phenotype of long-term allogeneic hematopoietic cells recipients compared to their donors
Cardiopulmonary performance in allogeneic hematopoietic cell transplantation recipients - evaluation of pre-transplant risk assessments
Impact of graft invariant natural killer T cells on early cytomegalovirus reactivation following allogeneic hematopoietic cell transplantation
Prophylactic Trimethoprim-Sulfamethoxazole for Allogeneic Hematopoietic Stem Cell Transplant Recipients During the Pre-engraftment Period
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients